Understanding health technology assessment.
To make the best use of scarce national health-care resources the adoption and diffusion of new technologies is now linked to evidence of their cost- as well as clinical effectiveness. Thus, the goal of medical device manufacturers today must be to provide value for money. This article details the process of conducting this assessment.
The Lewin Group, Quintile Scotland Limited, Heriot-Watt University Research Park, Edinburgh, UK. amcraig@quintiles.com
A M
AM
Craig
D003362:Cost-Benefit Analysis; D005060:Europe; D013673:Technology Assessment, Biomedical / Q000191:economics / Q000458:organization & administration